4-methoxyfuro[3,2-g]chromen-7-one

COC1=C2C=CC(=O)OC2=CC3=C1C=CO3

InChI=1S/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H3

BGEBZHIAGXMEMV-UHFFFAOYSA-N

Bergapten; 5-Methoxypsoralen; 484-20-8; bergaptene; Heraclin; Majudin; 4-Methoxy-7H-furo[3,2-g]chromen-7-one; BERGAPTAN; Psoraderm; 5-Mop; 5-Methoxy psoralen; O-Methylbergaptol; Geralen; 5-Methoxy-6,7-furanocoumarin; 5-Methoxyfuranocoumarin; 4-methoxyfuro[3,2-g]chromen-7-one; Pentaderm; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; 4-Methoxyfuro[3,2-g]benzopyran-7-one; 5-methoxypsoralene; NSC 95437; Bergaptene (DCF); 4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; 5-Methoxypsoralen with ultraviolet A therapy; NSC95437; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; NSC-95437; 4-Methoxy-furo[3,2-g]chromen-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; CHEMBL24171; 4FVK84C92X; DSSTox_CID_5560; DSSTox_RID_77830; DSSTox_GSID_25560; 5 methoxypsoralen; CAS-484-20-8; SMR000112435; CCRIS 4348; HSDB 3466; SR-05000002173; EINECS 207-604-5; BRN 0019560; UNII-4FVK84C92X; Pentaderm (TN); 5-methoxy-psoralen; MFCD00010272; 5-methoxyfurano[3,2-g]chromen-2-one; Spectrum_000794; 5-methoxy-2H-furo[3,2-g]chromen-2-one; BERGAPTEN [MI]; Spectrum2_000534; Spectrum3_000663; Spectrum4_001478; Spectrum5_000155; 5-Methoxypsoralen, 99%; 5-Methoxypsoralen;Heraclin; bmse000758; 5-Methoxypsoralen (obsol.); 7H-Furo[3, 4-methoxy-; Oprea1_562364; SCHEMBL50066; BSPBio_002325; KBioGR_002055; KBioSS_001274; SPECTRUM300546; 5-19-06-00004 (Beilstein Handbook Reference); MLS002207272; MLS002454380; Bergapten, analytical standard; DivK1c_000529; SPBio_000547; MEGxp0_000990; DTXSID1025560; ACon0_000984; ACon1_001979; CHEBI:18293; HMS501K11; KBio1_000529; KBio2_001274; KBio2_003842; KBio2_006410; KBio3_001545; ZINC57731; 5-METHOXYPSORALEN [IARC]; NINDS_000529; HMS1923G13; HMS2268M24; HMS3652F19; Pharmakon1600-00300546; 5-METHOXYPSORALEN [MART.]; 5-METHOXYPSORALEN [WHO-DD]; BCP30865; HY-N0370; TNP00299; Tox21_202357; Tox21_303255; BDBM50067880; CCG-39946; NSC755877; s4239; STK333038; AKOS000276715; DB12216; DS-2970; NSC-755877; SDCCGMLS-0066492.P001; IDI1_000529; NCGC00017357-01; NCGC00017357-02; NCGC00017357-03; NCGC00017357-04; NCGC00017357-05; NCGC00017357-06; NCGC00017357-07; NCGC00017357-08; NCGC00091582-01; NCGC00091582-02; NCGC00091582-03; NCGC00091582-04; NCGC00178705-01; NCGC00178705-02; NCGC00256998-01; NCGC00259906-01; AC-20189; AC-34208; NCI60_042121; SBI-0051583.P002; DB-051552; 4-Methoxy-7H-furo[3,2-g]benzopyran-7-one; B2840; FT-0603416; SW220008-1; 4-Methoxy-7H-furo[3,2-g]chromen-7-one #; C01557; D07521; AB00052148_06; AB00052148_07; 484B208; A827532; Q414779; Q-100536; SR-05000002173-2; SR-05000002173-3; SR-05000002173-5; BRD-K12968785-001-02-6; BRD-K12968785-001-03-4; BRD-K12968785-001-06-7; BRD-K12968785-001-11-7; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, .gamma.-lactone